|
Index of reports
> Cases with Neutropenia (74)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 74 Next >>
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient:
Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: arm b
Administration route: Oral
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Lapatinib
Dosage: arm c
Administration route: Oral
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: maintenance dose
Fluorouracil
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a physician from United Kingdom on 2012-08-07
Patient: female, weighing 93.7 kg (206.0 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae: 29 july 2011, last dose 546 mg
Docetaxel
Dosage: dose decreased, date of last dose prior to sae: 11/nov/2011
Indication: Breast Cancer
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011, last dose taken 75 mg
Start date: 2011-07-29
End date: 2011-11-11
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a physician from Philippines on 2012-08-03
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Docetaxel
Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Mucosta; Fluconazole; Acetaminophen; Tinzaparin; Tranexamic Acid; Omeprazole; Ciprofloxacin; Vitamin K TAB
Possible Herceptin side effects in 48 year old male
Reported by a physician from Germany on 2012-08-02
Patient: 48 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Agranulocytosis, Neoplasm Malignant, Neutropenia, Upper Gastrointestinal Haemorrhage, Skin Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Herceptin
Other drugs received by patient: Fluorouracil; Docetaxel; Cisplatin
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-19
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Gemcitabine Hydrochloride
Dosage: on days 1 and 8 every 21 days
Indication: Breast Cancer
Herceptin
Dosage: within 2 weeks after curative surgery until 52 weeks of therapy was completed
Paclitaxel
Dosage: over 1 h on days 1 and 8 every 21 days
Indication: Breast Cancer
Herceptin
Dosage: over 90 min on day 1
Indication: Breast Cancer
Herceptin
Dosage: over 30 min weekly
Possible Herceptin side effects in female
Reported by a physician from Belgium on 2012-07-19
Patient: female, weighing 66.0 kg (145.2 pounds)
Reactions: Tonsillitis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Taxotere
Dosage: 100mg cyclic
Indication: Breast Cancer
Start date: 2012-06-06
Herceptin
Dosage: 130mg cyclic
Indication: Breast Cancer
Start date: 2012-06-06
Lapatinib
Dosage: 1000mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-06
Possible Herceptin side effects in female
Reported by a physician from Germany on 2012-07-19
Patient: female
Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Herceptin
Indication: Breast Cancer
Xeloda
Indication: Breast Cancer
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-18
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia
Drug(s) suspected as cause:
Paclitaxel
Indication: Breast Cancer
Paclitaxel
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Gemcitabine Hydrochloride
Indication: Breast Cancer
Herceptin
Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
Indication: Breast Cancer
Herceptin
Dosage: after curative surgery until 52 weeks of therapy was completed.
Gemcitabine Hydrochloride
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Possible Herceptin side effects in female
Reported by a physician from China on 2012-07-17
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Suicide Attempt, Neutropenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Avastin
Dosage: last dose: 21 jul 2010
Indication: Breast Cancer
Start date: 2010-03-16
End date: 2010-08-30
Carboplatin
Dosage: last dose: 30 jun 2010
Indication: Breast Cancer
Start date: 2010-03-16
Docetaxel
Dosage: last dose: 30 jun 2010
Indication: Breast Cancer
Start date: 2010-03-16
Herceptin
Dosage: last dose: 21 jul 2010
Indication: Breast Cancer
Start date: 2010-03-16
End date: 2010-08-30
Clonazepam
Indication: Product Used FOR Unknown Indication
Possible Herceptin side effects in 55 year old female
Reported by a physician from Colombia on 2012-07-09
Patient: 55 year old female, weighing 69.0 kg (151.8 pounds)
Reactions: Neutropenia, Unevaluable Event
Drug(s) suspected as cause:
Herceptin
Possible Herceptin side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-22
Patient: 77 year old female
Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Cisplatin
Indication: Breast Cancer
Start date: 2012-02-08
Cisplatin
Indication: Gastric Cancer
Start date: 2012-02-08
Cisplatin
Start date: 2012-02-29
Herceptin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Cisplatin
Start date: 2012-02-29
Emend
Administration route: Oral
Start date: 2012-02-08
End date: 2012-03-02
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-22
Emend
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-02-08
End date: 2012-03-02
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-22
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Herceptin
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-29
Other drugs received by patient: Iperten; Allopurinol; Xenetix; Lovenox; Magnesium Sulfate; Cordarone; Bisoprolol Fumarate and Hydrochlorothiazide; Lorazepam; Potassium Chloride; Nexium; Acetaminophen; Tramadol HCL; Zofran
Possible Herceptin side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-19
Patient:
Reactions: Thrombosis, Headache, Device Related Infection, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hypotension, Anaemia, Hyperglycaemia, Dehydration, Neutropenia, Pain, Bone Pain, Hypokalaemia, Neutropenic Infection, Postoperative Wound Infection, Fatigue, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Lymphopenia, Alanine Aminotransferase Increased, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Arthralgia, Diarrhoea, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection
Drug(s) suspected as cause:
Vinorelbine Tartrate
Dosage: on day 8 and 15 of the 21 days cycle
Indication: Breast Cancer Metastatic
Herceptin
Docetaxel
Indication: Breast Cancer Metastatic
Herceptin
Indication: Breast Cancer Metastatic
Possible Herceptin side effects in 77 year old female
Reported by a physician from France on 2012-06-15
Patient: 77 year old female
Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Start date: 2012-02-29
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-22
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Herceptin
Start date: 2012-02-29
Emend
Dosage: on day 1, 2 and 3 of 14 day cycle
Indication: Vomiting
Start date: 2012-02-08
End date: 2012-03-02
Herceptin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Cisplatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-08
End date: 2012-02-29
Other drugs received by patient: Iperten; Nexium; Allopurinol; Xenetix; Bisoprolol Fumarate and Hydrochlorothiazide; Lovenox; Kaleorid LP; Zofran; Lorazepam; Acetaminophen; Tramadol HCL; Cordarone
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Philippines on 2012-06-15
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Docetaxel
Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Acetaminophen; Vitamin K TAB; Fluconazole; Mucosta; Ciproflaxacin; Omeprazole; Tranexamic Acid; Tinzaparin
Possible Herceptin side effects in female
Reported by a physician from Germany on 2012-06-14
Patient: female, weighing 86.0 kg (189.2 pounds)
Reactions: Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: form: vials, dose level: 6 mg/kg,permanently discontinued
Indication: Breast Cancer
Start date: 2010-05-04
End date: 2010-07-22
Carboplatin
Dosage: form: vials, dose level 5 auc, dose reduced.
Indication: Breast Cancer
Docetaxel
Start date: 2010-06-15
End date: 2010-07-22
Docetaxel
Dosage: form: vials, dose level: 60 mg/m2, dose reduced.
Indication: Breast Cancer
Carboplatin
Start date: 2010-06-15
End date: 2010-07-22
Other drugs received by patient: Emend; Bisoprolol Fumarate; Cellondan; Metoclopramide; Loperamide; Dexamethasone
Possible Herceptin side effects in female
Reported by a physician from Philippines on 2012-06-08
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Ciprofloxacin; Acetaminophen; Mucosta; Omeprazole; Fluconazole; Vitamin K TAB; Tinzaparin; Tranexamic Acid
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United Kingdom on 2012-06-08
Patient: female, weighing 93.0 kg (204.6 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae: 29 july 2011, last dose 546 mg
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011, last dose taken 75 mg
Start date: 2011-07-29
End date: 2011-11-11
Docetaxel
Dosage: dose decreased,
Indication: Breast Cancer
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Philippines on 2012-06-08
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Ciprofloxacin; Fluconazole; Tinzaparin; Acetaminophen; Omeprazole; Mucosta; Tranexamic Acid; Vitamin K TAB
Possible Herceptin side effects in female
Reported by a physician from Philippines on 2012-06-07
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Pneumonia, Cardio-Respiratory Arrest, Hepatic Failure, Febrile Neutropenia, Duodenal Ulcer, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Omeprazole; Ciprofloxacin; Fluconazole; Acetaminophen; Tinzaparin; Vitamin K TAB; Mucosta; Tranexamic Acid
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-05
Patient: female
Reactions: Vomiting, Wound Dehiscence, Nausea, Pain, Hyperglycaemia, Proteinuria, Ejection Fraction Decreased, Neutropenia, Hypertension, Blood Creatinine Increased, Thrombocytopenia, Infection
Drug(s) suspected as cause:
Herceptin
Dosage: for 23 weeks
Avastin
Dosage: for 23 weeks
Indication: Breast Cancer
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: total 54 weeks
Paclitaxel
Dosage: days 1, 8 and 15
Indication: Breast Cancer
Avastin
Dosage: total 54 weeks
Carboplatin
Dosage: auc=6 for 6 cycles
Indication: Breast Cancer
Possible Herceptin side effects in
Reported by a individual with unspecified qualification from Italy on 2012-06-05
Patient:
Reactions: Vomiting, Nausea, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Diarrhoea, Neutropenia, Asthenia, Leukopenia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Herceptin
Dosage: loading dose on day 1 of each cycle
Indication: Breast Cancer
Pegylated Liposomal Doxorubicin
Dosage: on day 1
Indication: Breast Cancer
Fluorouracil
Dosage: 200 mg/m2 as a continuous infusion from day 1 through day 21 to be repeated every 21 days for 8 cour
Indication: Breast Cancer
Herceptin
Dosage: on day 2 of each cycle
Cisplatin
Dosage: on day 1
Indication: Breast Cancer
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-30
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Paclitaxel
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Gemcitabine Hydrochloride
Indication: Breast Cancer
Herceptin
Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
Indication: Breast Cancer
Herceptin
Dosage: after curative surgery until 52 weeks of therapy was completed.
Paclitaxel
Indication: Breast Cancer
Gemcitabine Hydrochloride
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Possible Herceptin side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-30
Patient: female
Reactions: Pain, Pyrexia, Somnolence, Cardiac Disorder, Fatigue, Unevaluable Event, Hepatic Pain, Rash, Alcohol Poisoning, Stress, Syncope, Neoplasm Malignant, Mastectomy, Mental Disorder, Neutropenia, Feeling Abnormal, Asthenia, Bite, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Other drugs received by patient: Taxol; Oxycodone HCL
Possible Herceptin side effects in female
Reported by a physician from United Kingdom on 2012-05-29
Patient: female, weighing 93.0 kg (204.6 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Docetaxel
Dosage: dose decreased,
Indication: Breast Cancer
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011
Herceptin
Dosage: last dose prior to sae: 29 july 2011
Possible Herceptin side effects in female
Reported by a physician from United Kingdom on 2012-05-28
Patient: female, weighing 93.0 kg (204.6 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Herceptin
Dosage: last dose prior to sae: 29 july 2011
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011
Docetaxel
Dosage: dose decreased,
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-05-23
Patient: female, weighing 112.0 kg (246.4 pounds)
Reactions: White Blood Cell Count Decreased, Cellulitis, Pain in Extremity, Urinary Tract Infection, Constipation, International Normalised Ratio, Hypokalaemia, Haemoglobin Decreased, Hypoalbuminaemia, Neutropenia, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 900 milligram
Indication: Breast Cancer
Start date: 2012-03-02
Herceptin
Dosage: 224 milligram
Start date: 2012-04-20
End date: 2012-04-27
Abraxane
Dosage: 213 milligram
Start date: 2012-04-20
End date: 2012-04-27
Herceptin
Dosage: 224 milligram
Indication: Breast Cancer
Start date: 2012-03-02
Carboplatin
Dosage: 900 milligram
Start date: 2012-04-20
End date: 2012-04-27
Abraxane
Dosage: 213 milligram
Indication: Breast Cancer
Start date: 2012-03-02
Other drugs received by patient: Prochlorperazine; Ondansetron HCL; Ondansetron HCL; Prochlorperazine; Gentamicin; Miralax; Dexamethasone; Ambien; Potassium Chloride; Coumadin; Cozaar; Potassium Chloride; Zosyn; Vancomycin; Coumadin
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Israel on 2012-05-08
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Multi-Organ Failure, Urosepsis, Neutropenia, Myocardial Infarction, Cerebral Haemorrhage
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: maintenance dose. date of last dose prior to sae: 25 oct 2010, form: vial, dose level: 6 mg/kg
Carboplatin
Dosage: date of last dose prior to sae: 25 oct 2010, form: vial, dose level: 5 auc.
Indication: Breast Cancer
Avastin
Dosage: date of last dose prior to sae: 25 oct 2010, form: vial, dose level: 15 mg/kg.
Indication: Breast Cancer
Herceptin
Dosage: loading dose: 8 mg/kg on day 1 of cycle 1 only. form: vial
Indication: Breast Cancer
Docetaxel
Dosage: date of last dose prior to sae: 25 oct 2010, form: vial, dose level: 75 mg/m2.
Indication: Breast Cancer
Other drugs received by patient: Micropirin; Bondormin; Disothiazide; Simvastatin; Recital; Omeprazole; Ramipril
Possible Herceptin side effects in
Reported by a physician from United States on 2012-05-02
Patient:
Reactions: Abdominal Pain, Stomatitis, Vomiting, Dyspnoea, Nausea, Bone Pain, Palmar-Plantar Erythrodysaesthesia Syndrome, Myalgia, Fatigue, Diarrhoea, Exfoliative Rash, Dehydration, Sensory Disturbance, Nervous System Disorder, Neutropenia, Leukopenia
Drug(s) suspected as cause:
Herceptin
Dosage: as loading dose in cycle 1 (1 cycle was of 3 weeks)
Indication: Breast Cancer Metastatic
Xeloda
Administration route: Oral
Indication: Breast Cancer Metastatic
Vinorelbine Tartrate
Indication: Breast Cancer Metastatic
Herceptin
Possible Herceptin side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-01
Patient: 77 year old female
Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-03-14
Emend
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-02-08
End date: 2012-03-02
Herceptin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-03-14
Cisplatin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Herceptin
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-29
Emend
Administration route: Oral
Start date: 2012-02-08
End date: 2012-03-02
Cisplatin
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-29
Other drugs received by patient: Potassium Chloride; Allopurinol; Tramadol HCL; Lovenox; Nexium; Bisoprolol Fumarate and Hydrochlorothiazide; Lorazepam; Magnesium Sulfate; Iperten; Acetaminophen; Zofran; Xenetix; Cordarone
Possible Herceptin side effects in 31 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-04-24
Patient: 31 year old female
Reactions: Central Nervous System Lesion, Anaemia, Headache, Herpes Zoster, Viith Nerve Paralysis, Fatigue, Neoplasm Malignant, Eyelid Ptosis, Spinal Disorder, Neutropenia, Lethargy
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Product Used FOR Unknown Indication
Herceptin
Herceptin
Herceptin
Indication: Product Used FOR Unknown Indication
Herceptin
Other drugs received by patient: Paclitaxel; Vinorelbine Tartrate; Thiotepa
Page 1 Next >>
|
